📰 Note Regarding Forward Looking News
Page 2 - Note Regarding Forward Looking News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Note Regarding Forward Looking. Real-time updates on events, politics, business and more.
June 5, 2024
Highlights: Treasury Metals is holding its Annual and Special Meeting of Shareholders on June 26, 2024 at 1:00 p.m. (Eastern Time)The Special Committee and Board of Directors of the Company Unanimously Recommend that
May 31, 2024
Polestar announces that it expects to file its Annual Report for 2023 on Form 20-F and publish its preliminary unaudited financial and operational results for the first quarter of 2024 by the end of...
May 31, 2024
Happy Belly Food Group Inc. , a leading consolidator of emerging food brands is pleased to announce it has secured another real estate location for Heal Wellness , a fresh smoothie bowl, acai bowls,...
May 29, 2024
PRISMO METALS INC. Interim Managements Discussion and Analysis Quarterly Highlights Three...
May 29, 2024
Chief Commercial Officer and Director of Accounting to strengthen management team...
May 29, 2024
The Money 20/20 event, a premier global gathering for payments and financial services innovation, will provide an excellent platform for the HUB and BlackSwan…
May 29, 2024
GREENWICH, Conn., May 29, 2024 (GLOBE NEWSWIRE) -- Stardust Power Inc. (“Stardust Power” or the “Company”), a development stage American manufacturer of battery-grade lithium products, today announced the appointment of
May 29, 2024
HAMILTON, ON and BOSTON, May 29, 2024 /PRNewswire/ -- Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjugates as precision medicines,...
May 29, 2024
Presents Path for Compelling and Durable Topline Growth, Improved Operational Profitability and Increased Free Cash Flow Generation Details New Capital Allocation Priorities and Commitment to...
May 28, 2024
The Company1 enters agreement with Numab Therapeutics to acquire its wholly owned subsidiary2 for the global rights to NM26, a Phase 2-ready investigational, first-in-class bispecific antibody...